Antifungals utilized in treating dermatophytoses, including tinea cruris, target the synthesis of ergosterol, a vital component of fungal plasma membranes.

Deciding which agent to use should be based on patient compliance, cost, and medication accessibility, as there is insufficient data to directly compare the effectiveness of individual drugs and classes.

Oral preparations exist to manage tinea cruris and are indicated for chronic, recurrent, and recalcitrant disease.

A commonly used alternative treatment known as Whitfield's ointment has insufficient evidence of benefit.